Gastroesophageal Reflux Disease GERD Drugs and Devices Market: Proton Pump Inhibitors and North America Leading the Charge
The Gastroesophageal Reflux Disease GERD Drugs and Devices Market is experiencing significant and steady growth, with specific product and regional segments acting as primary catalysts. The market, valued at approximately USD 7.5 Billion in 2025, is projected to reach USD 12.3 Billion by 2035, driven by the critical roles of these segments in meeting the needs of a large and growing...
0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр